A detailed history of Nisa Investment Advisors, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 167 shares of URGN stock, worth $1,788. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167
Previous 75 122.67%
Holding current value
$1,788
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$12.7 - $17.92 $1,168 - $1,648
92 Added 122.67%
167 $2,000
Q2 2024

Jul 19, 2024

BUY
$12.72 - $19.2 $737 - $1,113
58 Added 341.18%
75 $1,000
Q1 2024

May 01, 2024

BUY
$13.81 - $19.33 $234 - $328
17 New
17 $0
Q3 2020

Oct 20, 2020

SELL
$18.81 - $26.42 $74,788 - $105,045
-3,976 Closed
0 $0
Q2 2020

Jul 27, 2020

SELL
$16.5 - $29.7 $3,861 - $6,949
-234 Reduced 5.56%
3,976 $104,000
Q3 2019

Oct 17, 2019

BUY
$23.83 - $36.44 $100,324 - $153,412
4,210 New
4,210 $100,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $244M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.